Send to

Choose Destination
Crit Care Med. 2001 Apr;29(4 Suppl):N92-6.

Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall.

Author information

University of Chicago, the Department of Pediatrics, the Section of Pediatric Infectious Diseases, Chicago, IL, USA.


Staphylococcus aureus is responsible for many nosocomial and community-acquired infections. Its evolving resistance to traditional antimicrobial chemotherapy and emerging prevalence outside of the healthcare environment are serious concerns. This review of the changing epidemiology of methicillin-resistant S. aureus, the emergence of vancomycin (glycopeptide)-resistant isolates, and the mechanisms of resistance to beta-lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center